12:29 PM
 | 
Jul 14, 2017
 |  BC Week In Review  |  Company News  |  Deals

Alcyone and Pfizer to build delivery platform for orphan and rare neurological disorders

Alcyone Lifesciences Inc. (Lowell, Mass.) and Pfizer Inc. (NYSE:PFE) partnered to evaluate Alcyone's Pulsar auto-intrathecal injector technology in...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >